A5041940996- Health Sciences Research and Education
- Health and Medical Research Impacts
- Advanced Breast Cancer Therapies
- Innovations in Medical Education
- Eosinophilic Esophagitis
- Opioid Use Disorder Treatment
- Neuroscience of respiration and sleep
- Healthcare cost, quality, practices
- Nutrition and Health in Aging
- Health Systems, Economic Evaluations, Quality of Life
- Pharmacological Effects and Toxicity Studies
- Vestibular and auditory disorders
- Pain Management and Opioid Use
- Head and Neck Cancer Studies
- Digital Imaging in Medicine
- Problem and Project Based Learning
- Reconstructive Surgery and Microvascular Techniques
- Medical Malpractice and Liability Issues
- Esophageal and GI Pathology
- Patient Safety and Medication Errors
- Hearing, Cochlea, Tinnitus, Genetics
- Neuroendocrine Tumor Research Advances
- Gastroesophageal reflux and treatments
- Cancer-related Molecular Pathways
- Metastasis and carcinoma case studies
Rutgers New Jersey Medical School
2018-2021
Rutgers, The State University of New Jersey
2018-2021
Columbia University Irving Medical Center
2021
Columbia University
2020
Objective Analyze the risk for perioperative complications associated with body mass index (BMI) class in patients undergoing head and neck free flap reconstruction. Study Design Setting Retrospective cohort study. Subjects Methods The National Surgical Quality Improvement Program (NSQIP) database was queried all cases of flaps between 2005 2014 (N = 2187). This population stratified into underweight, normal‐weight, overweight, obese BMI cohorts. Groups were compared demographics,...
Background/Aim: Palbociclib is an FDA-approved cyclin-dependent kinase inhibitor for the treatment of advanced breast cancer. Limited information available regarding toxicity palbociclib and concurrent radiation therapy. Case Report: Herein, we report a case esophageal in patient treated with A 63-year-old woman was followed by palliative The presented three days after completing therapy severe odynophagia, dysphagia found to have grade 2-3 ulcers. held on admission, resolution her symptoms...
OPEN ACCESSJuly 20, 2020Pharmacology, Pharmacotherapy, and Pharmacopolicy Through an Evidence-Based Medicine: A Novel Approach for First-Year Medical Students Alexander M. Mozeika, PharmD, Rijul Asri, James F. Theis, PhD, Carolyn K. Suzuki, PhD PharmD https://orcid.org/0000-0003-4037-7526 Fourth-Year Student, Department of Education, Rutgers New Jersey School E-mail Address: [email protected] Google Scholar More articles by this author , Asri Adjunct Assistant Professor, Biochemistry &...
INTRODUCTION: Palbociclib is a cyclin-dependent kinase inhibitor approved for the treatment of advanced breast cancer. Limited information available regarding toxicity palbociclib and concurrent radiation therapy (RT). In September 2019, FDA released safety announcement potential life-threatening interstitial lung disease pneumonitis in patients receiving CDK 4/6 inhibitors. A limited body work continues to describe adverse effects treatment. We present case patient with metastatic cancer...